HTG Molecular Diagnostics Inc (OTCPK:HTGMQ)
$ 0.0002 -0.000199 (-99.5%) Market Cap: - Enterprise Value: -2.58 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Q3 2020 HTG Molecular Diagnostics Inc Earnings Call Transcript

Nov 10, 2020 / 09:30PM GMT
Release Date Price: $59.51 (-1.52%)
Operator

Greetings, and welcome to the HTG Molecular Diagnostics, Inc. Third Quarter 2020 Earnings Call. (Operator Instructions) As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Paul Arndt with LifeSci Advisors. Thank you. You may begin.

Paul J. Arndt
LifeSci Advisors, LLC - Head of IR and MD, Communications

Thank you, operator. Earlier today, HTG released its financial results for the third quarter ended September 30, 2020.

Before we begin the call, let me remind you that the company's remarks include forward-looking statements within the meaning of the federal securities laws, including statements regarding increasing use of RNA-based biomarkers; expected growth in the molecular profiling market; anticipated growth in the company's RUO profiling business and related revenue; expectations regarding biopharma programs and collaborations; product development and commercialization activities; and the impact of and potential recovery from the ongoing COVID-19 pandemic.

These forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot